A human abuse potential study of Rexista
Phase of Trial: Phase III
Latest Information Update: 10 Oct 2018
Price : $35 *
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Therapeutic Use
- 10 Oct 2018 According to an Intellipharmaceutics International clinical component of study has been completed.Bioanalytical samples and statistical analysis for such studies are pending. An update on the results will be provided once the analysis is complete.
- 08 May 2018 Status changed from planning to recruiting, according to an Intellipharmaceutics media release.
- 08 May 2018 According to an Intellipharmaceutics media release, this study is being conducted by the Altasciences Clinical Research (Montreal).